City
Epaper

New strategy may enable accurate cancer monitoring from blood tests alone

By IANS | Updated: April 12, 2025 18:01 IST

New York, April 12 US researchers have found a new method that may help in monitoring cancer from ...

Open in App

New York, April 12 US researchers have found a new method that may help in monitoring cancer from blood tests more easily and accurately.

The study, led by researchers from Weill Cornell Medicine and the New York Genome Center, in the US, showed that the method may be useful for monitoring disease status in patients following treatment.

The method, based on whole-genome sequencing of DNA, also represents an important step toward the goal of routine blood test-based screening for early cancer detection.

"We're now entering an era of low-cost DNA sequencing, and in this study, we took advantage of that to apply whole-genome sequencing techniques that in the past would have been considered wildly impractical," said Dr. Dan Landau, Professor of Medicine, at Weill Cornell Medicine.

In the study, published in the journal Nature Methods, the team focussed on an error-correcting method in a low-cost commercial sequencing platform.

The error-correction method makes use of the redundant information in natural two-stranded DNA.

The researchers found it enabled a very high "depth" of coverage -- a measure of the sequencing data quality -- allowing the team to detect extremely low concentrations of circulating tumour DNA. It also greatly improved the accuracy of the technique.

Blood-test-based "liquid biopsy" technology for early cancer detection and monitoring of cancer burden in patients could revolutionise cancer care, said the researchers.

The team demonstrated the potential of the high-sensitivity, low-error approach by using it to detect and assess very low cancer levels in patients with bladder cancer and melanoma from blood samples alone.

"We were able, for example, to see increases in circulating tumour DNA levels after treatment in patients with cancers that progressed or recurred and declines in those levels in patients whose cancers had full or partial responses," said Dr. Alexandre Cheng, a postdoctoral researcher.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

NationalTerrorist hideout busted in J&K’s Poonch, IEDs and wireless sets recovered

NationalTwo murders in 24 hours shock Patna

Other SportsFeeling sorry for Pant because he is not changing his approach: Rayudu

BusinessKoyal.AI and Offbeet Media Group Announce Strategic Partnership at WAVES Summit 2025

MumbaiBEST to Revamp Over 1200 Bus Trips, Cutting Passenger Wait Times by 15 Minutes

Health Realted Stories

HealthTN govt to form flying squads to curb sedative drugs sale

HealthVaccine against whooping cough in pregnancy to boost antibodies, protect baby  

HealthIn Gujarat’s Sabarkantha, 36,000 people benefit from Ayushman Yojana in past one year

HealthHand hygiene not a luxury but cornerstone of safe healthcare: WHO

HealthHuman antibodies neutralise neurotoxins of 19 of world’s deadliest snakes